FDA Drug Recalls

Recalls / Class II

Class IID-525-2013

Product

BroveX PSE DM, Antihistamine, Cough Suppressant, Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-441-01

Affected lot / code info
Lot# 11A002 Exp. 12/12; Lot# 11A003 Exp. 12/12; Lot # 11A004 Exp. 12/12; Lot# 11A005 Exp. 12/12; Lot# 11L003 Exp. 10/13.

Why it was recalled

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Recalling firm

Firm
TG United, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
16275 Aviation Loop Dr, N/A, Brooksville, Florida 34604-6805

Distribution

Quantity
16,836 bottles - 100-count.
Distribution pattern
FL, MS, SC, LA and TX

Timeline

Recall initiated
2013-01-30
FDA classified
2013-06-04
Posted by FDA
2013-06-12
Terminated
2016-09-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-525-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls